<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Transl Myol</journal-id><journal-id journal-id-type="publisher-id">EJTM</journal-id><journal-title-group><journal-title>European Journal of Translational Myology</journal-title></journal-title-group><issn pub-type="ppub">2037-7452</issn><issn pub-type="epub">2037-7460</issn><publisher><publisher-name>PAGEPress Publications, Pavia, Italy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29686818</article-id><article-id pub-id-type="pmc">5895987</article-id><article-id pub-id-type="doi">10.4081/ejtm.2018.7278</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Effects of combined endurance and resistance training in Amyotrophic Lateral Sclerosis: A pilot, randomized, controlled study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Merico</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff001">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Cavinato</surname><given-names>Marianna</given-names></name><xref ref-type="aff" rid="aff001">1</xref><email>marianna.cavinato@ospedalesancamillo.net</email></contrib><contrib contrib-type="author"><name><surname>Gregorio</surname><given-names>Caterina</given-names></name><xref ref-type="aff" rid="aff002">2</xref><email>caterina.gregorio@ospedalesancamillo.net</email></contrib><contrib contrib-type="author"><name><surname>Lacatena</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff003">3</xref><email>alessandralacatena@gmail.com</email></contrib><contrib contrib-type="author"><name><surname>Gioia</surname><given-names>Elisabetta</given-names></name><xref ref-type="aff" rid="aff004">4</xref><email>elisabettagioia@live.it</email></contrib><contrib contrib-type="author"><name><surname>Piccione</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="aff001">1</xref><email>francesco.piccione@ospedalesancamillo.net</email></contrib><contrib contrib-type="author"><name><surname>Angelini</surname><given-names>Corrado</given-names></name><xref ref-type="aff" rid="aff001">1</xref><email>corrado.angelini@ospedalesancamillo.net</email></contrib></contrib-group><aff id="aff001"><label>(1)</label> Neurorehabilitation Department, San Camillo Hospital Foundation, <institution>Institute of Care and Research</institution>, Venice. <addr-line>Italy</addr-line></aff><aff id="aff002"><label>(2)</label> Department of Economic, mathematical and statistical sciences, <institution>University of Trieste</institution>, <addr-line>Italy</addr-line></aff><aff id="aff003"><label>(3)</label> Rehabilitation Department, <institution>Azienda Sanitaria Locale</institution>, Taranto, <addr-line>Italy</addr-line></aff><aff id="aff004"><label>(4)</label> Rehabilitation Department, <institution>Unit&#x000e0; Locale Socio-Sanitaria Serenissima</institution>, Venice, <addr-line>Italy</addr-line></aff><author-notes><corresp id="cor1">Via Alberoni, 70, 30126 Venice Phone Number: 0039 0412207517; <fax>number:</fax> 0039 0412207129. <email>antonio.merico@ospedalesancamillo.net</email></corresp><fn fn-type="COI-statement"><p><bold>Conflict of Interest</bold></p><p>The authors report no conflicts of interests.</p></fn><fn><p><bold>Author&#x02019;s contributions</bold></p><p>AM, FP and CA contributed to the conception and design of the project, the analysis and interpretation of data; in the editing of the work and in the critical review, in the final approval of the version to be published. AL and EG contributed to the conception and design of the project and the acquisition of and interpretation of data. MC and CG contributed to the analysis and interpretation of data ant to the editing of the work for the final approval of the version to be published.</p></fn></author-notes><pub-date pub-type="epub"><day>23</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><day>12</day><month>1</month><year>2018</year></pub-date><volume>28</volume><issue>1</issue><elocation-id>7278</elocation-id><history><date date-type="received"><day>05</day><month>1</month><year>2018</year></date><date date-type="rev-recd"><day>14</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2018</year></date></history><permissions><copyright-holder>Licensee PAGEPress, Italy</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">by-nc 4.0</uri>) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</license-p></license></permissions><abstract><p>Based on available evidence, muscle strengthening and cardiovascular exercises can help maintain function and not adversely affect the progression of disease in patients with ALS. However, this evidence is not sufficiently detailed to recommend a specific exercise prescription. The purpose of this project was to assess clinical outcomes of a combined exercise programme to increase knowledge of rehabilitation in ALS patients. 38 ALS patients were assigned randomly to two groups: one group underwent a specific exercise programme (ALS-EP) based on a moderate aerobic workout and isometric contractions, and the second group followed a standard neuromotor rehabilitation treatment. Objective evaluation consisted of cardiovascular measures, muscle strength and fatigue. Some positive effects of physical activity on ALS patients were found. Among the benefits, an overall improvement of functional independence in all patients, independently of the type of exercise conducted was seen. In addition, improvements in muscle power, oxygen consumption and fatigue were specifically observed in the ALS-EP group, all hallmarks of a training effect for the specific exercises. In conclusion, moderate intensity exercise is beneficial in ALS, helping in avoiding deconditioning and muscle atrophy resulting from progressive inactivity.</p></abstract><kwd-group><title>Key Words</title><kwd>Amyotrophic Lateral Sclerosis</kwd><kwd>neurorehabilitation</kwd><kwd>endurance training</kwd><kwd>isometric exercise</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="40"/><page-count count="9"/></counts></article-meta></front><body><sec><title>Ethical Publication Statement</title><p>We confirm that we have read the Journal&#x02019;s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p></sec><sec><title/><p><bold>M</bold>otor neuron diseases (MND) include a heterogeneous spectrum of inherited and sporadic clinical disorders of the upper motor neurons (UMN), lower motor neurons (LMN) or a combination of both. MND are characterized by progressive degeneration and loss of motor neurons in the spinal cord, brain stem, or motor cortex, and manifest clinically as muscle weakness, atrophy, and corticospinal tract signs and symptoms in various combinations.<sup><xref rid="ref1" ref-type="bibr">1</xref></sup> Differently from most of neuromuscular pathologies, where a moderate consistent exercise is recommended, physical activity in ALS is still much debated. In the past, patients were frequently suggested to avoid regular exercise in order to preserve muscle strength.<sup><xref rid="ref2" ref-type="bibr">2</xref></sup> In a recent study, it has been demonstrated that resistance and endurance exercise are safe to be performed without any worsening of outcomes in ALS patients.<sup><xref rid="ref3" ref-type="bibr">3</xref></sup> However, inactivity can involve cardiovascular deconditioning and atrophy from disuse that further superimpose the weakness caused by the ALS disease itself.<sup><xref rid="ref3" ref-type="bibr">3</xref></sup> If the reduced level of motor activity persists, ALS patients can develop severe deconditioning, muscle atrophy and tendon retractions that cause contractures, pain and higher difficulty in performing daily activities. Current clinical management for people with ALS is primarily individualized rehabilitation that may or may not include strengthening or aerobic exercise prescription. The continued lack of robust evidence regarding the efficacy and benefits of exercise in people with ALS may influence the availability, accessibility and quality of rehabilitation services provided for this group. Exercise, when prescribed appropriately, may be physically and psychologically important for people with ALS, especially in the earlier stages of the disease. Currently, rehabilitation of ALS patients is primarily individualized and sometimes may include strengthening and aerobic exercise.<sup><xref rid="ref4" ref-type="bibr">4</xref></sup> However, the lack of evidence of impact and efficacy of exercise in maintaining motor neuron integrity, motor function, and survival in ALS influences the availability, accessibility and quality of treatments.<sup><xref rid="ref4" ref-type="bibr">4</xref></sup> Previous animal studies had provided good basic scientific information about the effects of endurance exercise training at moderate intensity showing a higher survival and a reduction of motor neuron degeneration in mice with SOD-1-induced ALS.<sup><xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref></sup> Recent SOD-1 ALS mice study, have proposed molecular basis for the differential effects of specific exercise type and intensity in ALS; in particularly, the switching to glycolytic muscle metabolism and the activation of the fast motor unit induced by well-designed exercise programs (swimming), may provide synergistic beneficial effects for ALS patients.<sup><xref rid="ref7" ref-type="bibr">7</xref>,<xref rid="ref8" ref-type="bibr">8</xref></sup> Considering that, in animal studies the neurons controlling fast fibers were noted to degenerate early in the course of ALS, other authors advise to minimize stress on fast twitch muscle fibers.<sup><xref rid="ref9" ref-type="bibr">9</xref>,<xref rid="ref10" ref-type="bibr">10</xref></sup> However, in humans, findings are more heterogeneous. In humans, an association between physical activity and ALS was postulated by some studies; recently a European Population-Based Case&#x02013;Control.<sup><xref rid="ref11" ref-type="bibr">11</xref></sup> Study concluded that physical activity is not a risk and may eventually be protective against the disease. Another review concluded that current evidence for physical activity as a risk factor in MND is limited.<sup><xref rid="ref12" ref-type="bibr">12</xref></sup> Several authors have attempted to assess functional improvements after moderate exercise highlighting short-term benefits in producing a slower rate of decline in terms of endurance, spasticity and motor deterioration, but not in muscle strength.<sup><xref rid="ref4" ref-type="bibr">4</xref>,<xref rid="ref10" ref-type="bibr">10</xref>,<xref rid="ref13" ref-type="bibr">13-15</xref></sup> On the other hand, other studies lay out some concerns on the exercise programme that should consider the underlying pathophysiology of ALS, avoiding high-intensity exercise that can stress the fast-twitch muscle fibers and being focused on reduction of spasticity, strengthening of weak muscles, and minimization of fatigue.<sup><xref rid="ref10" ref-type="bibr">10</xref></sup> Overall, aerobic exercises, early and at mild to moderate intensities, seem to be beneficial in muscle strengthening and cardiovascular exercise can help maintain function, prevent further deconditioning and atrophy and not adversely affect the progression of the disease.<sup><xref rid="ref3" ref-type="bibr">3-10</xref></sup> However, this evidence is not sufficiently detailed to recommend a specific treatment and there is complete lack of randomised clinical trials examining aerobic training in ALS patients. The present study was aimed at evaluating the effect of a moderate exercise programme based on aerobic training and isometric sub-maximal contractions of muscles, on changes in muscle strength, fatigue and cardiovascular parameters. This programme was designed to strengthen the weak muscles, facilitate musculoskeletal resistance and minimize fatigue to prevent deconditioning and atrophy not directly caused by the disease.</p></sec><sec id="sec1-1"><title>Materials and Methods</title><sec id="sec2-1"><title>Participants</title><p>Forty-six patients admitted to the Foundation San Camillo Hospital for rehabilitation were consecutively enrolled in this study. All patients fulfilled the revised El Escorial criteria for clinically probable, laboratory-supported probable, or definite ALS.<sup><xref rid="ref20" ref-type="bibr">20</xref></sup> Inclusion criteria included: sporadic or familial ALS; mild to moderate disabilities assessed by Sinaki-Mulder stages I-II-III.<sup><xref rid="ref19" ref-type="bibr">19</xref></sup> Exclusion criteria were as follows: history of other neurological diseases, lost ability to walk (any assistive device was allowed), mechanical ventilation, heart or respiratory failure, metabolic disorders, any severe active neuropsychological illness making a patient unable to understand and perform the instructions. All patients included in our study were taking riluzole. None carried the SOD1 mutation. Before being enrolled in the study, an evaluation of oxygen consumption was carried out. No participants reported dyspnoea or respiratory insufficiency as assessed by forced vital capacity and nocturnal oximetry. Patients were assigned randomly to two groups: one group (26 patients, 9 females, mean age 61.6&#x000b1;10) underwent a specific exercise programme (ALS-EP) and the second group (20 patients, 8 females, mean age 59.2&#x000b1;14) followed the standard neuromotor rehabilitation treatment (ALS-SNR). Both groups had no significant difference in their age, gender, time from disease onset, percentage of bulbar onset, rate of progression and disability at time of inclusion in the study (<xref ref-type="table" rid="table001">Table 1</xref>). The rate of progression of ALS was calculated by dividing the ALSFRS-R total score by symptom duration (months) and seems to represent an independent and robust prognostic biomarker for ALS.<sup><xref rid="ref21" ref-type="bibr">21</xref></sup> Functional disability was assessed by the revised ALS Functional Rating Scale (ALSFRS-r) and the bulbar involvement was scored using the part of the ALSFRS-r assessing speech, salivation and swallowing. The experimental procedure was approved by the local Ethics Committee for medical research, and all participants gave informed written consent.</p></sec><sec id="sec2-2"><title>Exercise Protocol</title><p>The exercise protocol has been set based on the recommendations of the American College of Sports Medicine (ACSM).<sup><xref rid="ref22" ref-type="bibr">22</xref></sup> The specific exercise programme consisted of a series of exercises that included an individualized progressive training of muscular strengthening and aerobic endurance, under the supervision of two experienced physical therapists. To be sure to avoid muscle damage, we have chosen the submaximal isometric contraction to strengthen the weak muscles with a score of 3, 4- or 4 as measured by the Medical Research Council scale (MRC). The repetitions were 3 for each bilateral muscle segment and were performed for a time interval, determined by calculating 80% of the time of maximum contraction; each repetition was separated by 30 seconds of rest. The exercise was carried out using rubber bands with a sequential system of progressive resistance and followed by stretching. The use of elastic bands reduces the risk of orthopedic and muscular injuries. The series of exercises was performed daily for 5 weeks. Aerobic exercise was performed to a sub-maximal intensity of 65% of maximum heart rate adjusted for age, with a duration of 15-20 minutes (in Tables 2a-2b the HR corresponding to 65% are summarized for each patient). Based on the weakness pattern and the level of disability of each patient, we chose to use a cycle ergometer, ergometry arm-leg and/or treadmill. Exercises were carried out with continuous monitoring of heart rate and saturimetry. The series of exercises was performed daily for 5 weeks, and overall each exercise session lasted about one hour. The second group of patients (ALS-SNR) followed a 5-week programme of standard neurorehabilitation, consisting of one-hour sessions of stretching, active mobilization and general muscle reinforcement; this last treatment has been set within the limits of patient reported fatigue and avoiding eccentric and concentric contractions. Furthermore, all patients underwent speech, occupational and psychological therapies, based on individual clinical and functional profiles.</p></sec><sec id="sec2-3"><title>Clinical assessment</title><p>All patients were assessed at the beginning and at the end of treatment by two evaluators with experience in neurorehabilitation, blinded to the treatment patients received. Functional autonomy was assessed by the Functional Independence Measure (FIM). The six-minute walk test (6MWT) was used to identify gait speed thresholds supporting functional ambulation and the effects of fatigue on patients&#x02019; walking capacity. Muscle strength was evaluated by the MRC Muscle Grading Scale and a dynamometer able to quantify muscle strength reliably (CIT Technics BV, Groningen, the Netherlands), with a reset button and a curved applicator. The muscular strength was assessed by the mean value of three consecutive muscular contractions of Deltoid, Biceps, Wrist extensor, Ileopsoas, Quadriceps femoris, Tibialis anterior. Positions of patient and instrument were standardized as described by Van der Ploeg et al.<sup><xref rid="ref23" ref-type="bibr">23</xref></sup> The total MRC sum score (MRCSS), ranging from 0 (total paralysis) to 60 (normal strength), was calculated by the sum of the MRC score of the 6 muscles on both sides, each muscle graded from 0 to 5. Gas analysis was undertaken using the ergometer metabolic system Fitmate (Cosmed&#x000a9;, Rome, Italy) (24-25) following a 5-min warm-up at 30-W cycling and a pedalling cadence up to achieve 65% of the predicted maximum heart rate (HRmax) for 10 minutes. The HRmax was predicted from 220 beats min - age. Speed, resting heart rate and during exercise, ventilation and oxygen uptake were monitored, and the linear regression relating to HR and the volume of O2 (VO2) at submaximal work was extrapolated. Sub maximal oxygen consumption (VO2submax) was measured by Fitmate, using the following formula: VO2submax (ml/min/kg) = (HR &#x000d7; SV) &#x000d7; [a-vO2], where SV is stroke volume, and a-v O2 is arteriovenous oxygen difference in the oxygen content of the blood between the arterial blood and the venous blood. VO2submax was measured at the same load of exercise before the aerobic training and at the end of the study. Finally, the Fatigue Severity Scale (FSS) was administered to know the degree of fatigue and its effect on the activities of the patients. All patients performed a creatine kinase (CK) test to evaluate potential muscle damage as a consequence of level and intensity of physical exercise. No patients showed altered CK values before and after treatment.</p></sec><sec id="sec2-4"><title>Statistical analysis</title><p>To test for a statistically significant effect of exercise over the treatment period and whether this effect changed in relation to type of treatment, a mixed model, with group (exercise vs. control) and time (T0 vs. T1) as factors, was applied to the FSS and FIM scales, the cardio-respiratory and muscular measurements.<sup><xref rid="ref26" ref-type="bibr">26</xref>,<xref rid="ref27" ref-type="bibr">27</xref></sup> Model assumptions were verified through analysis of residuals. In case of heterogeneity, a variance covariate structure was introduced into the model and data were transformed with Box-Cox method in case of evidence of non-normality. Homogeneity of the two groups at T0 was assessed in relation to the ALSFRSr scale, duration of disease, progression rate and age using either the t-test or the non-parametric Mann-Witney test according to whether the data were found Gaussian or not. Correlation between outcome measures was tested with either Pearson or non-parametric Kendall test. Bonferroni correction was then used.<sup><xref rid="ref28" ref-type="bibr">28</xref></sup> A Shapiro-Wilk test was performed to test for normality of the data. Data were tested at 95% significance level.</p></sec></sec><sec id="sec1-2"><title>Results</title><p>At T0, both groups had the same degree of disability evaluated by the ALS-FRSr scale (p=0.27). Five bulbar onset patients were in the ALS-SNR group and one was in the ALS-EP group. Eight patients dropped out and 38 completed the study: the remaining patients were 23 attributable to the group of the specific exercise protocol and 15 to the group of standard rehabilitation. The cardiovascular and metabolic data of ALS-EP and ALS-SNP groups are summarized in <xref ref-type="table" rid="table003">Table 3</xref>. Significant differences in clinical and functional assessment are summarized in <xref ref-type="table" rid="table004">Table 4</xref>. The FIM scale was found correlated with Ventilation during exercise (r=0.25,p&#x0003c;0.01), resting HR (r=- 0.20,p=0.01), Right Biceps strength (r=0.24; p&#x0003c;0.01) and the six-minute walk test measurements (r=0.23,p&#x0003c;0.01). The FSS scale correlated with the Oxygen Consumption (r=0.26,p&#x0003c;0.01), resting HR (r=0.29,p&#x0003c;0.01), Right Biceps and Tibial strength (r=- 0.21,p=0.01,r=- 0.19,p=0.02, respectively), the MRC Sum Score (r=- 0.28,p&#x0003c;0.01) and the Six Minute walk test (r=- 0.27,p&#x0003c;0.01).</p></sec><sec id="sec1-3"><title>Discussion</title><p>The positive effects of exercise in healthy people are, in general, well documented and have been largely demonstrated. Accordingly, physical inactivity is associated with increasing risk of many adverse health conditions.<sup><xref rid="ref29" ref-type="bibr">29</xref></sup> This is more relevant in the process of aging or some neuromuscular disorders where a progressive degradation of the neuromuscular system manifests by a steady decline in muscle mass and strength. In fact, at the level of the single motor unit, aging and disease can be associated with muscle atrophy. Furthermore, recent data show that physical activity promotes reinnervation of muscle fibers in aging.<sup><xref rid="ref30" ref-type="bibr">30-35</xref></sup> In ALS, conflicting results have weakened the role of physical exercise, though a growing number of data indicates the safe and the beneficial effects of physical activity.<sup><xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref36" ref-type="bibr">36</xref>,<xref rid="ref37" ref-type="bibr">37</xref></sup> Among the benefits, we found an overall improvement of the score on functional independence scale in all patients, independently of the type of exercise conducted (specific programme or standard neuromotor rehabilitation treatment). In addition, improvements in muscle power (expressed by the MRC scale), oxygen consumption (measured by VO2submax) and fatigue were specifically observed in the EP group, all hallmarks of a training effect for the specific exercise programme. As for physical activity in general, improvements can potentially reduce the strains of daily living by increasing reserve capacities.<sup><xref rid="ref38" ref-type="bibr">38</xref></sup> This would allow ALS patients to meet the physiological demands required for activities of daily living more effectively, reflecting an increase of their score on functional independence scale. Examining our combined exercise programme, our purpose was to assess the clinical efficacy of a programme of moderate aerobic and isometric exercises, through an objective assessment of muscle strength, fatigue and The positive effects of exercise in healthy people are, in general, well documented and have been largely demonstrated. Accordingly, physical inactivity is associated with increasing risk of many adverse health conditions.<sup><xref rid="ref29" ref-type="bibr">29</xref></sup> This is more relevant in the process of aging or some neuromuscular disorders where a progressive degradation of the neuromuscular system manifests by a steady decline in muscle mass and strength. In fact, at the level of the single motor unit, aging and disease can be associated with muscle atrophy. Furthermore, recent data show that physical activity promotes reinnervation of muscle fibers in aging.<sup><xref rid="ref30" ref-type="bibr">30-35</xref></sup> In ALS, conflicting results have weakened the role of physical exercise, though a growing number of data indicates the safe and the beneficial effects of physical activity.<sup><xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref36" ref-type="bibr">36</xref>,<xref rid="ref37" ref-type="bibr">37</xref></sup> Among the benefits, we found an overall improvement of the score on functional independence scale in all patients, independently of the type of exercise conducted (specific programme or standard neuromotor rehabilitation treatment). In addition, improvements in muscle power (expressed by the MRC scale), oxygen consumption (measured by VO2submax) and fatigue were specifically observed in the EP group, all hallmarks of a training effect for the specific exercise programme. As for physical activity in general, improvements can potentially reduce the strains of daily living by increasing reserve capacities.<sup><xref rid="ref38" ref-type="bibr">38</xref></sup> This would allow ALS patients to meet the physiological demands required for activities of daily living more effectively, reflecting an increase of their score on functional independence scale. Examining our combined exercise programme, our purpose was to assess the clinical efficacy of a programme of moderate aerobic and isometric exercises, through an objective assessment of muscle strength, fatigue and be reinforced, and the number of repetitions per session. In our study, a submaximal isometric contraction was chosen to avoid muscle damage from mechanical and bioelectrical overload, or metabolic stress, especially to the fast twitch fatigable muscular fibers. During isometric exercise, in fact, the muscle is activated, maintaining a constant length, and reaches a state of maximum tension safely. Recent studies have also shown that isometric exercises can maximize motor unit activity in terms of increase of the firing rates of active motor units and recruitment of other motor units that usually are inactive.<sup><xref rid="ref40" ref-type="bibr">40</xref></sup> This mechanism can be crucial in strengthening a denervated muscle and could explain the improvement of MRC muscle scale that we observed in our patients after the five-week training programme. In summary, the use of a combined protocol of aerobic and resistance training (well below maximal effort) seems to have positive effects in terms of energy and fatigue required to perform activities of daily living, and is associated with increased function and independence. A lower requirement for oxygen by the working muscle during submaximal tasks indicates better walking economy. However, the significant increase in muscular strength expressed by the MRCSS not supported by a change of dynamometric measures of the examined muscles could indicate that the submaximal isometric contractions used were too mild and precautionary. suggest that specific rehabilitation programs can counter out the progressive motor deficit of ALS. We believe that moderate exercise can be a reasonable recommendation to establish specific exercise therapy and to improve clinical practice in ALS Centers. Integration with bio molecular data and/or biopsy and a longer exercise programme would be useful to evaluate the effect of exercise on motoneuron efficiency, evidencing cellular and metabolic changes and to verify the effect of rehabilitative intervention on the natural history of the disease.</p></sec></body><back><ack><title>Acknowledgments and Funding</title><p>Authors thanks for collaboration Simonetta Rossi BSc, Veronica Santoro BSc, Valentina Vianello Bsc, Alfons Baba BSc. Funding: None.</p></ack><glossary><title>List of acronyms</title><def-list><def-item><term>ALS</term><def><p>Amyotrophic Lateral Sclerosis</p></def></def-item><def-item><term>ALS-EP</term><def><p>specific exercise programme</p></def></def-item><def-item><term>LMN</term><def><p>lower motor neurons</p></def></def-item><def-item><term>MND</term><def><p>motor neuron diseases</p></def></def-item><def-item><term>UMN</term><def><p>upper motor neurons</p></def></def-item><def-item><term>ALSFS-r</term><def><p>Amyotrophic Lateral Sclerosis Functional Scale- revised</p></def></def-item><def-item><term>FIM</term><def><p>Functional Independence Measure</p></def></def-item><def-item><term>FSS</term><def><p>Fatigue Severity Scale</p></def></def-item><def-item><term>MRCSS</term><def><p>Medical Research Concil sum score.</p></def></def-item><def-item><term>HR 65%</term><def><p>heart rate corresponded to 65% for aerobic training</p></def></def-item><def-item><term>RHR</term><def><p>Resting heart rate</p></def></def-item><def-item><term>VO<sub>2</sub></term><def><p>Oxygen Consumption, ml/min/kg</p></def></def-item><def-item><term>6 MW</term><def><p>Six Minute Walk Test</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Swash</surname><given-names>M</given-names></name></person-group>
<article-title>Clinical features and diagnosis of amyotrophic lateral sclerosis</article-title>. <person-group person-group-type="editor"><name><surname>Brown Jr</surname><given-names>RH</given-names></name><name><surname>Meininger</surname><given-names>V</given-names></name><name><surname>Swash</surname><given-names>M</given-names></name></person-group>, editors. <article-title>Amyotrophic Lateral Sclerosis</article-title>. <publisher-loc>London</publisher-loc>: <publisher-name>Martin Dunitz</publisher-name>, <year>2000</year>: <fpage>330</fpage>.</mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Coble</surname><given-names>NO</given-names></name><name><surname>Maloney</surname><given-names>FP</given-names></name></person-group>
<article-title>Interdisciplinary rehabilitation of multiple sclerosis and neuromuscular disorders</article-title>. <person-group person-group-type="editor"><name><surname>Maloney</surname><given-names>FP</given-names></name><name><surname>Burks</surname><given-names>JS</given-names></name><name><surname>Ringel</surname><given-names>SP</given-names></name></person-group> editor(s). <article-title>Effects of Exercise in Neuromuscular Disease</article-title>. <publisher-loc>New York</publisher-loc>: <publisher-name>JB Lippincott</publisher-name>, <year>1985</year>:<fpage>228</fpage>&#x02013;<lpage>38</lpage>.</mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clawson</surname><given-names>LL</given-names></name><name><surname>Cudkowicz</surname><given-names>M</given-names></name></person-group>, Krivickas<etal/>
<article-title>A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis</article-title>. <source>Amyotroph Lateral Scler Frontotemporal Degener</source>
<year>2017</year>;<volume>30</volume>:<fpage>1</fpage>-<lpage>9</lpage></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dal</surname><given-names>Bello-Haas V</given-names></name><name><surname>Florence</surname><given-names>JM</given-names></name></person-group>
<article-title>Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease</article-title>. <source>Cochrane Database Syst Rev</source>
<year>2013</year>;<volume>5</volume>:<fpage>Art</fpage>. No.: CD005229</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaspar</surname><given-names>BK</given-names></name><name><surname>Frost</surname><given-names>LM</given-names></name><name><surname>Christian</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis</article-title>. <source>Ann Neurol</source>
<year>2005</year>;<volume>57</volume>:<fpage>649</fpage>-<lpage>55</lpage>.<pub-id pub-id-type="pmid">15852403</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deforges</surname><given-names>S</given-names></name><name><surname>Branchu</surname><given-names>J</given-names></name><name><surname>Biondi</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis</article-title>. <source>J Physiol</source>
<year>2009</year>;<volume>587</volume> (Pt 14):<fpage>3561</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="pmid">19491245</pub-id></mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desseille</surname><given-names>C</given-names></name><name><surname>Deforges</surname><given-names>S</given-names></name><name><surname>Biondi</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice</article-title>. <source>Front Mol Neurosci</source>
<year>2017</year>;<volume>10</volume>:<fpage>33</fpage>.<pub-id pub-id-type="pmid">28243190</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grondard</surname><given-names>C</given-names></name><name><surname>Biondi</surname><given-names>O</given-names></name><name><surname>Pariset</surname><given-names>C</given-names></name><etal/></person-group>
<source>Exercise-Induced Modulation of Calcineurin Activity Parallels the Time Course of Myofibre Transitions J Cell Physiol</source>
<year>2008</year>;<volume>214</volume>:<fpage>126</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">17559060</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>D</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases</article-title>. <source>J Neurosci</source>
<volume>20</volume>, <fpage>2534</fpage>&#x02013;<lpage>42</lpage>.</mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>AJ</given-names></name><name><surname>Byl</surname><given-names>NN</given-names></name></person-group>
<article-title>A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis</article-title>. <source>J Neurol Phys Ther</source>
<year>2009</year>;<volume>33</volume>:<fpage>68</fpage>-<lpage>87</lpage>.<pub-id pub-id-type="pmid">19556916</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pupillo</surname><given-names>E</given-names></name><name><surname>Messina</surname><given-names>P</given-names></name><name><surname>Giussiani</surname><given-names>G</given-names></name></person-group>
<source>Physical Activity and Amyotrophic Lateral Sclerosis: A European Population-BasedCase&#x02013;Control Study Ann Neurol</source>
<year>2014</year>;<volume>75</volume>:<fpage>708</fpage>&#x02013;<lpage>16</lpage></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harwood</surname><given-names>CA</given-names></name><name><surname>McDermott</surname><given-names>CJ</given-names></name><name><surname>Shaw</surname><given-names>PJ</given-names></name></person-group>
<article-title>Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence</article-title>. <source>Amyotroph Lateral Scler</source>
<year>2009</year>;<volume>10</volume>:<fpage>191</fpage>-<lpage>204</lpage>.<pub-id pub-id-type="pmid">19263258</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carreras</surname><given-names>I</given-names></name><name><surname>Yuruker</surname><given-names>S</given-names></name><name><surname>Aytan</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Moderate exercise delays the motor performance decline in a transgenic model of ALS</article-title>. <source>Brain Res</source>
<year>2010</year>;<volume>1313</volume>:<fpage>192</fpage>-<lpage>201</lpage>.<pub-id pub-id-type="pmid">19968977</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drory</surname><given-names>VE</given-names></name><name><surname>Goltsman</surname><given-names>E</given-names></name><name><surname>Goldman</surname><given-names>J</given-names></name><etal/></person-group>
<source>The value of muscle exercise in patients with amyotrophic lateral sclerosis J Neurol Sci</source>
<year>2001</year>;<volume>191</volume>:<fpage>133</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="pmid">11677004</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunetta</surname><given-names>C</given-names></name><name><surname>Lizio</surname><given-names>A</given-names></name><name><surname>Sansone</surname><given-names>VA</given-names></name><etal/></person-group>
<article-title>Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial</article-title>. <source>J Neurol</source>
<year>2016</year>;<volume>263</volume>:<fpage>52</fpage>-<lpage>60</lpage>.<pub-id pub-id-type="pmid">26477027</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal"><article-title>Kilmer DD The effect of a high resistance exercise programme in slowly progressive neuromuscular disease</article-title>. <source>Arch Phys Med Rehabil</source>
<year>1994</year>;<volume>75</volume>:<fpage>560</fpage>-<lpage>3</lpage>.<pub-id pub-id-type="pmid">8185450</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milner-Brown</surname><given-names>HS</given-names></name><name><surname>Miller</surname><given-names>RG</given-names></name></person-group>
<article-title>Muscle strengthening through high-resistance weight training in patients with neuromuscular disorders</article-title>. <source>Arch Phys Med Rehabil</source>
<year>1988</year>;<volume>69</volume>:<fpage>14</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">3337636</pub-id></mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cup</surname><given-names>EH</given-names></name><name><surname>Pieterse</surname><given-names>AJ</given-names></name><name><surname>Ten</surname><given-names>Broek-Pastoor JM</given-names></name><etal/></person-group>
<source>Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review Arch Phys Med Rehabil</source>
<year>2007</year>;<volume>88</volume>:<fpage>1452</fpage>-<lpage>64</lpage>.</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinaki</surname><given-names>M</given-names></name></person-group>, <article-title>Mulder DW Rehabilitation techniques for patients with amyotrophic lateral sclerosis</article-title>. <source>Mayo Clin Proc</source>
<year>1978</year>;<volume>53</volume>:<fpage>173</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">628227</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>KR</given-names></name><name><surname>Crump</surname><given-names>S</given-names></name><name><surname>al-Sarraj</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: a clinicopathological study</article-title>. <source>J Neurol Sci</source>. <year>1995</year>;<volume>129</volume>
<fpage>Suppl</fpage>:11-2.</mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labra</surname><given-names>L</given-names></name><name><surname>Menon</surname><given-names>P</given-names></name><name><surname>Byth</surname><given-names>KS</given-names></name><etal/></person-group>
<source>Rate of disease progression: a prognostic biomarker in ALS J Neurol Neurosurg Psychiatry</source>
<year>2016</year>;<volume>87</volume>:<fpage>628</fpage>-<lpage>32</lpage></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>CE</given-names></name><name><surname>Blissmer</surname><given-names>B</given-names></name><name><surname>Deschenes</surname><given-names>MR</given-names></name><etal/></person-group>
<article-title>American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise</article-title>. <source>American College of Sports Medicine Med Sci Sports Exerc</source>
<year>2011</year>;<volume>43</volume>:<fpage>1334</fpage>-<lpage>59</lpage>.<pub-id pub-id-type="pmid">21694556</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der</surname><given-names>Ploeg</given-names></name><name><surname>Oosterhuis</surname><given-names>HJ</given-names></name><name><surname>Reuvekamp</surname><given-names>J.</given-names></name></person-group>
<article-title>Measuring muscle strength</article-title>. <source>J Neurol</source>
<year>1984</year>;<volume>231</volume>:<fpage>200</fpage>-<lpage>3</lpage>.<pub-id pub-id-type="pmid">6512574</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Bassett</surname><given-names>DR Jr</given-names></name><name><surname>Thompson</surname><given-names>DL</given-names></name><name><surname>Fitzhugh</surname><given-names>EC</given-names></name></person-group>
<article-title>Validation of the Cosmed Fitmate for prediction of maximal oxygen consumption</article-title>. <source>J Strength Cond Res</source>
<year>2011</year>;<volume>25</volume>:<fpage>2573</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">21869633</pub-id></mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>DC</given-names></name><name><surname>Lasasso</surname><given-names>H</given-names></name><name><surname>Austin</surname><given-names>MD</given-names></name><etal/></person-group>
<article-title>Validation of Cosmed's FitMate in measuring exercise metabolism</article-title>. <source>Res Sports Med</source>
<year>2007</year>;<volume>15</volume>:<fpage>67</fpage>-<lpage>75</lpage>.<pub-id pub-id-type="pmid">17365953</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Faraway</surname><given-names>JJ</given-names></name></person-group>
<article-title>Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models</article-title>. <publisher-loc>London (UK)</publisher-loc>: <publisher-name>Chapman &#x00026; Hall/CRC</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>West</surname><given-names>BT</given-names></name><name><surname>Welch</surname><given-names>KB</given-names></name><name><surname>Galecki</surname><given-names>AT</given-names></name></person-group>
<article-title>Linear mixed models: a practical guide using statistical software</article-title>. <publisher-loc>London (UK)</publisher-loc>: <publisher-name>Chapman &#x00026; Hall/CRC</publisher-name>; <year>2006</year>. doi: 10.1201/b17198.</mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huberty</surname><given-names>C.J</given-names></name><name><surname>Morris</surname><given-names>J.D</given-names></name></person-group>
<article-title>Multivariate Analysis versus Multiple Univariate Analyses</article-title>. <source>Psychological Bulletin</source>
<year>1989</year>;<volume>105</volume>:<fpage>302</fpage>-<lpage>8</lpage>.</mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>FW</given-names></name><name><surname>Roberts</surname><given-names>CK</given-names></name><name><surname>Laye</surname><given-names>MJ</given-names></name></person-group>
<article-title>Lack of exercise is a major cause of chronic diseases Compr Physiol</article-title>. <source>Author manuscript; available in PMC</source>
<year>2014</year> Nov 23.</mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deschenes</surname><given-names>MR</given-names></name></person-group>
<article-title>Motor unit and neuromuscular junction remodeling with aging</article-title>. <source>Curr Aging Sci</source>
<year>2011</year>;<volume>4</volume>:<fpage>209</fpage>-<lpage>20</lpage>.<pub-id pub-id-type="pmid">21529328</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosole</surname><given-names>S</given-names></name><name><surname>Carraro</surname><given-names>U</given-names></name><name><surname>Kern</surname><given-names>H</given-names></name><etal/></person-group>; <article-title>Long-term high-level exercise promotes muscle reinnervation with age</article-title>. <source>J Neuropathol Exp Neurol</source>. <year>2014</year>;<volume>73</volume>:<fpage>284</fpage>-<lpage>94</lpage>.<pub-id pub-id-type="pmid">24607961</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>32</surname><given-names>Mosole S</given-names></name><name><surname>Carraro</surname><given-names>U</given-names></name><name><surname>Kern</surname><given-names>H</given-names></name><name><surname>Loefler</surname><given-names>S</given-names></name><name><surname>Zampieri</surname><given-names>S.</given-names></name></person-group>
<article-title>Use it or Lose It: Tonic Activity of Slow Motoneurons Promotes Their Survival and Preferentially Increases Slow Fiber-Type Groupings in Muscles of Old Lifelong Recreational Sportsmen</article-title>. <source>Eur J Transl Myol</source>
<year>2016</year>;<volume>26</volume>:<fpage>5972</fpage>. doi: 10.4081/ejtm.2016.5972. eCollection 2016 Sep 15.<pub-id pub-id-type="pmid">28078066</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willand</surname><given-names>MP</given-names></name></person-group>
<article-title>Electrical Stimulation Enhances Reinnervation After Nerve Injury</article-title>. <source>Eur J Transl Myol</source>
<year>2015</year>;<volume>25</volume>:<fpage>243</fpage>-<lpage>8</lpage>. doi: 10.4081/ejtm.2015.5243. eCollection 2015 Aug 24. Review.<pub-id pub-id-type="pmid">26913163</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajer</surname><given-names>S</given-names></name></person-group>
<article-title>Mobility disorders and pain, interrelations that need new research concepts and advanced clinical commitments</article-title>. <source>Eur J Transl Myol</source>
<year>2017</year>;<volume>27</volume>(<issue>4</issue>):<fpage>7179</fpage>. doi: 10.4081/ejtm.2017.7179. eCollection 2017 Dec 5.<pub-id pub-id-type="pmid">29299226</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>GA</given-names></name><name><surname>Dalton</surname><given-names>BH</given-names></name><name><surname>Gilmore</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Maintaining Motor Units into Old Age: Running the Final Common Pathway</article-title>. <source>Eur J Transl Myol</source>
<year>2017</year>;<volume>27</volume>(<issue>1</issue>):<fpage>6597</fpage>. doi: 10.4081/ejtm.2017.6597. eCollection 2017 Feb 24<pub-id pub-id-type="pmid">28458809</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>AC</given-names></name><name><surname>Alves</surname><given-names>M</given-names></name><name><surname>Nogueira</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?</article-title>
<source>J Neurol Sci</source>
<year>1999</year>;<volume>169</volume>:<fpage>69</fpage>&#x02013;<lpage>75</lpage><pub-id pub-id-type="pmid">10540010</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>AJ</given-names></name><name><surname>PT</surname><given-names>Byl NN</given-names></name></person-group>
<article-title>A systematic review of the effect of moderate intensity exercise on function and disease progression in amyotrophic lateral sclerosis</article-title>. <source>J Neurol Phys Ther</source>
<year>2009</year>;<volume>33</volume>:<fpage>68</fpage>-<lpage>87</lpage>.<pub-id pub-id-type="pmid">19556916</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>CW</given-names></name><name><surname>Sinaki</surname><given-names>M.</given-names></name></person-group>
<article-title>Rehabilitation management of the ALS patient</article-title>. <person-group person-group-type="editor"><name><surname>Belsh</surname><given-names>JM</given-names></name><name><surname>Schiffman</surname><given-names>PL</given-names></name></person-group>, editors. <article-title>Amyotrophic lateral sclerosis: diagnosis and management for the clinician</article-title>. <publisher-loc>Amonk (Ny)</publisher-loc>: <publisher-name>Futura Publishing Co., Inc</publisher-name>; <year>1996</year> p. <fpage>315</fpage>-<lpage>331</lpage>.</mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macko</surname><given-names>RF</given-names></name><name><surname>Smith</surname><given-names>GV</given-names></name><name><surname>Dobrovolny</surname><given-names>CL</given-names></name><etal/></person-group>
<article-title>Treadmill training improves fitness reserve in chronic stroke patients</article-title>. <source>Arch Phys Med Rehabil</source>
<year>2001</year>;<volume>82</volume>:<fpage>879</fpage>-<lpage>84</lpage>.<pub-id pub-id-type="pmid">11441372</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Luca</surname><given-names>CJ</given-names></name><name><surname>Kline</surname><given-names>JC</given-names></name></person-group>
<article-title>Influence of proprioceptive feedback on the firing rate and recruitment of motoneurons</article-title>. <source>J Neural Eng</source>
<year>2012</year>;<volume>9</volume>:<fpage>016007</fpage>.<pub-id pub-id-type="pmid">22183300</pub-id></mixed-citation></ref></ref-list></back><floats-group><table-wrap id="table001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Baseline characteristics of exercise programme group (ALS-EP) and standard neuromotor rehabilitation treatment group (ALS-SNT). ALSFS-R, Amyotrophic Lateral Sclerosis Functional Scale- revised; FIM, Functional Independence Measure; FSS, Fatigue Severity Scale; MRC sum score, Medical Research Concil sum score.</p></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="right" valign="top" rowspan="1" colspan="1">ALS-EP n=23</th><th align="right" valign="top" rowspan="1" colspan="1">ALS-SNT n=15</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th align="right" valign="top" rowspan="1" colspan="1">mean&#x000b1;SD</th><th align="right" valign="top" rowspan="1" colspan="1">mean&#x000b1;SD</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, yr</td><td align="right" valign="top" rowspan="1" colspan="1">61.6 &#x000b1; 10.6</td><td align="right" valign="top" rowspan="1" colspan="1">59.8 &#x000b1; 14.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender, F/M</td><td align="right" valign="top" rowspan="1" colspan="1">10/13</td><td align="right" valign="top" rowspan="1" colspan="1">4/10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Onset,Spinal/Bulbar</td><td align="right" valign="top" rowspan="1" colspan="1">22/1</td><td align="right" valign="top" rowspan="1" colspan="1">15/0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration, mo</td><td align="right" valign="top" rowspan="1" colspan="1">30.2&#x000b1;11.8</td><td align="right" valign="top" rowspan="1" colspan="1">30.3&#x000b1;6.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALSFRS-R</td><td align="right" valign="top" rowspan="1" colspan="1">36.1&#x000b1;4.71</td><td align="right" valign="top" rowspan="1" colspan="1">34.5&#x000b1;3.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALSFRS-R, Bulbar subscore</td><td align="right" valign="top" rowspan="1" colspan="1">9.89&#x000b1;1.7</td><td align="right" valign="top" rowspan="1" colspan="1">9.73&#x000b1;1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rate of progression</td><td align="right" valign="top" rowspan="1" colspan="1">0.4&#x000b1;0.18</td><td align="right" valign="top" rowspan="1" colspan="1">0.4&#x000b1;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FIM</td><td align="right" valign="top" rowspan="1" colspan="1">79.73&#x000b1;6.1</td><td align="right" valign="top" rowspan="1" colspan="1">78.0&#x000b1;8.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FSS</td><td align="right" valign="top" rowspan="1" colspan="1">5.4&#x000b1;0.27</td><td align="right" valign="top" rowspan="1" colspan="1">5.4&#x000b1;0.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resting heart rate, bpm</td><td align="right" valign="top" rowspan="1" colspan="1">80.52&#x000b1;5.4</td><td align="right" valign="top" rowspan="1" colspan="1">78.80&#x000b1;8.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxygen Consumption, ml/min/kg</td><td align="right" valign="top" rowspan="1" colspan="1">15.36&#x000b1;2.0</td><td align="right" valign="top" rowspan="1" colspan="1">12.67&#x000b1;1.60</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ventilation, L/min</td><td align="right" valign="top" rowspan="1" colspan="1">25.95&#x000b1;5.2</td><td align="right" valign="top" rowspan="1" colspan="1">24.49&#x000b1;5.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MRC Sum Score</td><td align="right" valign="top" rowspan="1" colspan="1">40.26&#x000b1;2.45</td><td align="right" valign="top" rowspan="1" colspan="1">39.87&#x000b1;4.24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Right Biceps Muscle, kg/min</td><td align="right" valign="top" rowspan="1" colspan="1">66.96&#x000b1;24.95</td><td align="right" valign="top" rowspan="1" colspan="1">73.13&#x000b1;16.99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Left Biceps Muscle, kg/min</td><td align="right" valign="top" rowspan="1" colspan="1">70.65&#x000b1;19.53</td><td align="right" valign="top" rowspan="1" colspan="1">80.27&#x000b1;14.60</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Right Tibial Muscle, kg/min</td><td align="right" valign="top" rowspan="1" colspan="1">77.11&#x000b1;34.92</td><td align="right" valign="top" rowspan="1" colspan="1">57.93&#x000b1;27.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Left Tibial Muscle, kg/min</td><td align="right" valign="top" rowspan="1" colspan="1">77.21&#x000b1;36.11</td><td align="right" valign="top" rowspan="1" colspan="1">60.80&#x000b1;32.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Six Minute Walk Test, mt</td><td align="right" valign="top" rowspan="1" colspan="1">265.17&#x000b1;81.37</td><td align="right" valign="top" rowspan="1" colspan="1">236.26&#x000b1;76.26</td></tr></tbody></table></table-wrap><table-wrap id="table002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>The cardiovascular and metabolic data of ALS-EP patients; I (initial), F (final); HR 65% (heart rate corresponded to 65% for aerobic training); RHR (Resting heart rate bpm); VO2 (Oxygen Consumption, ml/min/kg); 6 MW (Six Minute Walk Test, mt); MRCss (MRC Sum Score)</p></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">ALS-EP</th><th align="left" valign="top" rowspan="1" colspan="1">age</th><th align="left" valign="top" rowspan="1" colspan="1">HR 65%</th><th align="left" valign="top" rowspan="1" colspan="1">RHR I</th><th align="left" valign="top" rowspan="1" colspan="1">RHR F</th><th align="left" valign="top" rowspan="1" colspan="1">VO2 I</th><th align="left" valign="top" rowspan="1" colspan="1">VO2 F</th><th align="left" valign="top" rowspan="1" colspan="1">6MW I</th><th align="left" valign="top" rowspan="1" colspan="1">MRCss I</th><th align="left" valign="top" rowspan="1" colspan="1">MRCSs F</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">88</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">13</td><td align="right" valign="top" rowspan="1" colspan="1">8,1</td><td align="right" valign="top" rowspan="1" colspan="1">152,5</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="right" valign="top" rowspan="1" colspan="1">54</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">83</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">18,1</td><td align="right" valign="top" rowspan="1" colspan="1">15,4</td><td align="right" valign="top" rowspan="1" colspan="1">392</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="right" valign="top" rowspan="1" colspan="1">65</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">89</td><td align="right" valign="top" rowspan="1" colspan="1">82</td><td align="right" valign="top" rowspan="1" colspan="1">14,1</td><td align="right" valign="top" rowspan="1" colspan="1">9</td><td align="right" valign="top" rowspan="1" colspan="1">294,5</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">85</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">12,9</td><td align="right" valign="top" rowspan="1" colspan="1">12,2</td><td align="right" valign="top" rowspan="1" colspan="1">316</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="right" valign="top" rowspan="1" colspan="1">53</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">77</td><td align="right" valign="top" rowspan="1" colspan="1">16,4</td><td align="right" valign="top" rowspan="1" colspan="1">8,6</td><td align="right" valign="top" rowspan="1" colspan="1">48</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">73</td><td align="right" valign="top" rowspan="1" colspan="1">15,4</td><td align="right" valign="top" rowspan="1" colspan="1">9,5</td><td align="right" valign="top" rowspan="1" colspan="1">216</td><td align="right" valign="top" rowspan="1" colspan="1">36</td><td align="right" valign="top" rowspan="1" colspan="1">41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="right" valign="top" rowspan="1" colspan="1">65</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">68</td><td align="right" valign="top" rowspan="1" colspan="1">17,3</td><td align="right" valign="top" rowspan="1" colspan="1">11,4</td><td align="right" valign="top" rowspan="1" colspan="1">256</td><td align="right" valign="top" rowspan="1" colspan="1">34</td><td align="right" valign="top" rowspan="1" colspan="1">42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="right" valign="top" rowspan="1" colspan="1">68</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">74</td><td align="right" valign="top" rowspan="1" colspan="1">67</td><td align="right" valign="top" rowspan="1" colspan="1">12,8</td><td align="right" valign="top" rowspan="1" colspan="1">9,3</td><td align="right" valign="top" rowspan="1" colspan="1">315</td><td align="right" valign="top" rowspan="1" colspan="1">40</td><td align="right" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="right" valign="top" rowspan="1" colspan="1">64</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">15,6</td><td align="right" valign="top" rowspan="1" colspan="1">11,5</td><td align="right" valign="top" rowspan="1" colspan="1">375</td><td align="right" valign="top" rowspan="1" colspan="1">40</td><td align="right" valign="top" rowspan="1" colspan="1">50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="right" valign="top" rowspan="1" colspan="1">59</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">84</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">16,7</td><td align="right" valign="top" rowspan="1" colspan="1">13,8</td><td align="right" valign="top" rowspan="1" colspan="1">340</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">42</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="right" valign="top" rowspan="1" colspan="1">73</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">88</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">15,9</td><td align="right" valign="top" rowspan="1" colspan="1">13,1</td><td align="right" valign="top" rowspan="1" colspan="1">325</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="right" valign="top" rowspan="1" colspan="1">63</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">83</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">17,5</td><td align="right" valign="top" rowspan="1" colspan="1">12,5</td><td align="right" valign="top" rowspan="1" colspan="1">238</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="right" valign="top" rowspan="1" colspan="1">26</td><td align="right" valign="top" rowspan="1" colspan="1">125</td><td align="right" valign="top" rowspan="1" colspan="1">89</td><td align="right" valign="top" rowspan="1" colspan="1">82</td><td align="right" valign="top" rowspan="1" colspan="1">17,8</td><td align="right" valign="top" rowspan="1" colspan="1">13,6</td><td align="right" valign="top" rowspan="1" colspan="1">275</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="right" valign="top" rowspan="1" colspan="1">67</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">85</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">18,3</td><td align="right" valign="top" rowspan="1" colspan="1">14,3</td><td align="right" valign="top" rowspan="1" colspan="1">245</td><td align="right" valign="top" rowspan="1" colspan="1">45</td><td align="right" valign="top" rowspan="1" colspan="1">52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="right" valign="top" rowspan="1" colspan="1">62</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">77</td><td align="right" valign="top" rowspan="1" colspan="1">19,5</td><td align="right" valign="top" rowspan="1" colspan="1">14,4</td><td align="right" valign="top" rowspan="1" colspan="1">135</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="right" valign="top" rowspan="1" colspan="1">49</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">73</td><td align="right" valign="top" rowspan="1" colspan="1">14,6</td><td align="right" valign="top" rowspan="1" colspan="1">10,1</td><td align="right" valign="top" rowspan="1" colspan="1">305</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="right" valign="top" rowspan="1" colspan="1">57</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">68</td><td align="right" valign="top" rowspan="1" colspan="1">15,2</td><td align="right" valign="top" rowspan="1" colspan="1">13,1</td><td align="right" valign="top" rowspan="1" colspan="1">225</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">48</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="right" valign="top" rowspan="1" colspan="1">60</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">74</td><td align="right" valign="top" rowspan="1" colspan="1">67</td><td align="right" valign="top" rowspan="1" colspan="1">13,4</td><td align="right" valign="top" rowspan="1" colspan="1">11,4</td><td align="right" valign="top" rowspan="1" colspan="1">325</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="right" valign="top" rowspan="1" colspan="1">61</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">13,2</td><td align="right" valign="top" rowspan="1" colspan="1">9,1</td><td align="right" valign="top" rowspan="1" colspan="1">225</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="right" valign="top" rowspan="1" colspan="1">74</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">84</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">14,6</td><td align="right" valign="top" rowspan="1" colspan="1">8</td><td align="right" valign="top" rowspan="1" colspan="1">260</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">49</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="right" valign="top" rowspan="1" colspan="1">63</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">77</td><td align="right" valign="top" rowspan="1" colspan="1">73</td><td align="right" valign="top" rowspan="1" colspan="1">14</td><td align="right" valign="top" rowspan="1" colspan="1">11,2</td><td align="right" valign="top" rowspan="1" colspan="1">325</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">76</td><td align="right" valign="top" rowspan="1" colspan="1">69</td><td align="right" valign="top" rowspan="1" colspan="1">13,2</td><td align="right" valign="top" rowspan="1" colspan="1">7,9</td><td align="right" valign="top" rowspan="1" colspan="1">325</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="right" valign="top" rowspan="1" colspan="1">50</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">75</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">13,7</td><td align="right" valign="top" rowspan="1" colspan="1">8,9</td><td align="right" valign="top" rowspan="1" colspan="1">186</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">51</td></tr></tbody></table></table-wrap><table-wrap id="table003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>The cardiovascular and metabolic data of ALS-SNP patients</p></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">ALS-SNT</th><th align="left" valign="top" rowspan="1" colspan="1">age</th><th align="left" valign="top" rowspan="1" colspan="1">HR 65%</th><th align="left" valign="top" rowspan="1" colspan="1">RHR I</th><th align="left" valign="top" rowspan="1" colspan="1">RHR F</th><th align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> I</th><th align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> F</th><th align="left" valign="top" rowspan="1" colspan="1">6MW I</th><th align="left" valign="top" rowspan="1" colspan="1">6MW F</th><th align="left" valign="top" rowspan="1" colspan="1">MRCss I</th><th align="left" valign="top" rowspan="1" colspan="1">MRCSs F</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="right" valign="top" rowspan="1" colspan="1">54</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">87</td><td align="right" valign="top" rowspan="1" colspan="1">85</td><td align="right" valign="top" rowspan="1" colspan="1">13</td><td align="right" valign="top" rowspan="1" colspan="1">22,4</td><td align="right" valign="top" rowspan="1" colspan="1">157,5</td><td align="right" valign="top" rowspan="1" colspan="1">158,5</td><td align="right" valign="top" rowspan="1" colspan="1">43</td><td align="right" valign="top" rowspan="1" colspan="1">46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="right" valign="top" rowspan="1" colspan="1">65</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">91</td><td align="right" valign="top" rowspan="1" colspan="1">88</td><td align="right" valign="top" rowspan="1" colspan="1">13,5</td><td align="right" valign="top" rowspan="1" colspan="1">21</td><td align="right" valign="top" rowspan="1" colspan="1">157,5</td><td align="right" valign="top" rowspan="1" colspan="1">158,9</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="right" valign="top" rowspan="1" colspan="1">57</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">83</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">13,9</td><td align="right" valign="top" rowspan="1" colspan="1">19,3</td><td align="right" valign="top" rowspan="1" colspan="1">172,3</td><td align="right" valign="top" rowspan="1" colspan="1">172</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="right" valign="top" rowspan="1" colspan="1">58</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">86</td><td align="right" valign="top" rowspan="1" colspan="1">84</td><td align="right" valign="top" rowspan="1" colspan="1">10,4</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">242</td><td align="right" valign="top" rowspan="1" colspan="1">242</td><td align="right" valign="top" rowspan="1" colspan="1">48</td><td align="right" valign="top" rowspan="1" colspan="1">51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="right" valign="top" rowspan="1" colspan="1">57</td><td align="right" valign="top" rowspan="1" colspan="1">110</td><td align="right" valign="top" rowspan="1" colspan="1">85</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">12,4</td><td align="right" valign="top" rowspan="1" colspan="1">21</td><td align="right" valign="top" rowspan="1" colspan="1">158</td><td align="right" valign="top" rowspan="1" colspan="1">157,5</td><td align="right" valign="top" rowspan="1" colspan="1">42</td><td align="right" valign="top" rowspan="1" colspan="1">45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="right" valign="top" rowspan="1" colspan="1">33</td><td align="right" valign="top" rowspan="1" colspan="1">120</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">80</td><td align="right" valign="top" rowspan="1" colspan="1">9,4</td><td align="right" valign="top" rowspan="1" colspan="1">23,7</td><td align="right" valign="top" rowspan="1" colspan="1">250</td><td align="right" valign="top" rowspan="1" colspan="1">250</td><td align="right" valign="top" rowspan="1" colspan="1">41</td><td align="right" valign="top" rowspan="1" colspan="1">43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="right" valign="top" rowspan="1" colspan="1">60</td><td align="right" valign="top" rowspan="1" colspan="1">105</td><td align="right" valign="top" rowspan="1" colspan="1">82</td><td align="right" valign="top" rowspan="1" colspan="1">80</td><td align="right" valign="top" rowspan="1" colspan="1">12</td><td align="right" valign="top" rowspan="1" colspan="1">24</td><td align="right" valign="top" rowspan="1" colspan="1">335</td><td align="right" valign="top" rowspan="1" colspan="1">337</td><td align="right" valign="top" rowspan="1" colspan="1">39</td><td align="right" valign="top" rowspan="1" colspan="1">40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="right" valign="top" rowspan="1" colspan="1">63</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">56</td><td align="right" valign="top" rowspan="1" colspan="1">70</td><td align="right" valign="top" rowspan="1" colspan="1">15</td><td align="right" valign="top" rowspan="1" colspan="1">30</td><td align="right" valign="top" rowspan="1" colspan="1">150</td><td align="right" valign="top" rowspan="1" colspan="1">170</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="right" valign="top" rowspan="1" colspan="1">29</td><td align="right" valign="top" rowspan="1" colspan="1">125</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">75</td><td align="right" valign="top" rowspan="1" colspan="1">15,1</td><td align="right" valign="top" rowspan="1" colspan="1">30,2</td><td align="right" valign="top" rowspan="1" colspan="1">305</td><td align="right" valign="top" rowspan="1" colspan="1">307</td><td align="right" valign="top" rowspan="1" colspan="1">44</td><td align="right" valign="top" rowspan="1" colspan="1">45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="right" valign="top" rowspan="1" colspan="1">45</td><td align="right" valign="top" rowspan="1" colspan="1">115</td><td align="right" valign="top" rowspan="1" colspan="1">81</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">18</td><td align="right" valign="top" rowspan="1" colspan="1">26,6</td><td align="right" valign="top" rowspan="1" colspan="1">280</td><td align="right" valign="top" rowspan="1" colspan="1">290</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="right" valign="top" rowspan="1" colspan="1">76</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">11,9</td><td align="right" valign="top" rowspan="1" colspan="1">17</td><td align="right" valign="top" rowspan="1" colspan="1">168</td><td align="right" valign="top" rowspan="1" colspan="1">167</td><td align="right" valign="top" rowspan="1" colspan="1">36</td><td align="right" valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">90</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">71</td><td align="right" valign="top" rowspan="1" colspan="1">11</td><td align="right" valign="top" rowspan="1" colspan="1">28,2</td><td align="right" valign="top" rowspan="1" colspan="1">188</td><td align="right" valign="top" rowspan="1" colspan="1">188</td><td align="right" valign="top" rowspan="1" colspan="1">36</td><td align="right" valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="right" valign="top" rowspan="1" colspan="1">73</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">79</td><td align="right" valign="top" rowspan="1" colspan="1">12,8</td><td align="right" valign="top" rowspan="1" colspan="1">26,7</td><td align="right" valign="top" rowspan="1" colspan="1">275</td><td align="right" valign="top" rowspan="1" colspan="1">280</td><td align="right" valign="top" rowspan="1" colspan="1">40</td><td align="right" valign="top" rowspan="1" colspan="1">41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="right" valign="top" rowspan="1" colspan="1">75</td><td align="right" valign="top" rowspan="1" colspan="1">95</td><td align="right" valign="top" rowspan="1" colspan="1">78</td><td align="right" valign="top" rowspan="1" colspan="1">76</td><td align="right" valign="top" rowspan="1" colspan="1">9,9</td><td align="right" valign="top" rowspan="1" colspan="1">17</td><td align="right" valign="top" rowspan="1" colspan="1">270</td><td align="right" valign="top" rowspan="1" colspan="1">271</td><td align="right" valign="top" rowspan="1" colspan="1">36</td><td align="right" valign="top" rowspan="1" colspan="1">36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="right" valign="top" rowspan="1" colspan="1">64</td><td align="right" valign="top" rowspan="1" colspan="1">100</td><td align="right" valign="top" rowspan="1" colspan="1">72</td><td align="right" valign="top" rowspan="1" colspan="1">69</td><td align="right" valign="top" rowspan="1" colspan="1">12,6</td><td align="right" valign="top" rowspan="1" colspan="1">22,3</td><td align="right" valign="top" rowspan="1" colspan="1">395</td><td align="right" valign="top" rowspan="1" colspan="1">398</td><td align="right" valign="top" rowspan="1" colspan="1">38</td><td align="right" valign="top" rowspan="1" colspan="1">38</td></tr></tbody></table></table-wrap><table-wrap id="table004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Functional and cardiopulmonary changes after training.</p></caption><table frame="box" rules="all"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">ALS-EP n=23</th><th align="left" valign="top" rowspan="1" colspan="1">ALS-SNT n=15</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">mean&#x000b1;SD</td><td align="left" valign="top" rowspan="1" colspan="1">mean&#x000b1;SD</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FIM</td><td align="left" valign="top" rowspan="1" colspan="1">4.56&#x000b1;1.16<xref ref-type="fn" rid="tfn1">*</xref><xref ref-type="fn" rid="tfn2">&#x000b0;</xref></td><td align="left" valign="top" rowspan="1" colspan="1">1.8&#x000b1;1.37<xref ref-type="fn" rid="tfn1">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FSS</td><td align="left" valign="top" rowspan="1" colspan="1">1.29&#x000b1;0.21<xref ref-type="fn" rid="tfn1">*</xref></td><td align="left" valign="top" rowspan="1" colspan="1">-0.21&#x000b1;0.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resting heart rate, bpm</td><td align="left" valign="top" rowspan="1" colspan="1">-5.7&#x000b1;1.29</td><td align="left" valign="top" rowspan="1" colspan="1">-0.53&#x000b1;4.47</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxygen Consumption, ml/min/kg</td><td align="left" valign="top" rowspan="1" colspan="1">-4.16&#x000b1;1.71<xref ref-type="fn" rid="tfn1">*</xref><xref ref-type="fn" rid="tfn2">&#x000b0;</xref></td><td align="left" valign="top" rowspan="1" colspan="1">0.10&#x000b1;1.53</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ventilation, L/min</td><td align="left" valign="top" rowspan="1" colspan="1">-3.59&#x000b1;4.73</td><td align="left" valign="top" rowspan="1" colspan="1">0.34&#x000b1;4.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MRC Sum Score</td><td align="left" valign="top" rowspan="1" colspan="1">7.83&#x000b1;1.80<xref ref-type="fn" rid="tfn1">*</xref><xref ref-type="fn" rid="tfn2">&#x000b0;</xref></td><td align="left" valign="top" rowspan="1" colspan="1">1.53&#x000b1;1.13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Right Biceps, kg/min</td><td align="left" valign="top" rowspan="1" colspan="1">9.26&#x000b1;13.17<xref ref-type="fn" rid="tfn1">*</xref><xref ref-type="fn" rid="tfn2">&#x000b0;</xref></td><td align="left" valign="top" rowspan="1" colspan="1">-0.73&#x000b1;1.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Left Biceps, kg/min</td><td align="left" valign="top" rowspan="1" colspan="1">8.1810.09&#x000b1;</td><td align="left" valign="top" rowspan="1" colspan="1">-0.54&#x000b1;1.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Right Tibial, kg/min</td><td align="left" valign="top" rowspan="1" colspan="1">9.28&#x000b1;12.96</td><td align="left" valign="top" rowspan="1" colspan="1">-0.13&#x000b1;1.46</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Left Tibial, kg/min</td><td align="left" valign="top" rowspan="1" colspan="1">8.44&#x000b1;17.27</td><td align="left" valign="top" rowspan="1" colspan="1">-1.00&#x000b1;1.41</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Six Minute Walk Test, mt</td><td align="left" valign="top" rowspan="1" colspan="1">71.56&#x000b1;50.72</td><td align="left" valign="top" rowspan="1" colspan="1">2.90&#x000b1;5.48</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p>* Significant effect of time, p&#x0003c;0.05</p></fn><fn id="tfn2"><p>&#x000b0; Significant difference between groups, p&#x0003c;0.05</p></fn></table-wrap-foot></table-wrap></floats-group></article>